These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 16876685

  • 1. Treatment of combined aortic regurgitation and systemic hypertension: Insights from an animal model study.
    Couet J, Gaudreau M, Lachance D, Plante E, Roussel E, Drolet MC, Arsenault M.
    Am J Hypertens; 2006 Aug; 19(8):843-50. PubMed ID: 16876685
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E, Gaudreau M, Lachance D, Drolet MC, Roussel E, Gauthier C, Lapointe E, Arsenault M, Couet J.
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transcriptional changes associated with recovery from heart failure in the SHR.
    Brooks WW, Shen S, Conrad CH, Goldstein RH, Deng LL, Bing OH.
    J Mol Cell Cardiol; 2010 Sep; 49(3):390-401. PubMed ID: 20547165
    [Abstract] [Full Text] [Related]

  • 14. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of estrogen and angiotensin-converting enzyme inhibitor on vascular remodeling in ovariectomized spontaneously hypertensive rats.
    García MP, Giménez J, Serna M, Salom MG, Bonacasa B, Carbonell LF, Quesada T, Hernández I.
    Menopause; 2006 Dec; 13(3):397-403. PubMed ID: 16735936
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
    Dhahri W, Couet J, Roussel É, Drolet MC, Arsenault M.
    Life Sci; 2013 Jan 17; 92(1):26-34. PubMed ID: 23142240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.